Will Cardiovascular Disease Prevention Widen Health Inequalities?
article has not abstract
Vyšlo v časopise:
Will Cardiovascular Disease Prevention Widen Health Inequalities?. PLoS Med 7(8): e32767. doi:10.1371/journal.pmed.1000320
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000320
Souhrn
article has not abstract
Zdroje
1. GrahamH
2009 Health inequalities, social determinants and public health policy. Policy and Politics 37 463 479
2. Department of Health 2009 Putting prevention first. London: Department of Health. Available: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_083822. Accessed 20 July 2010
3. Zosia Kmietowicz 2009 Five yearly checks for over 40s will save 650 lives a year, says government. BMJ 338 b1334 doi:10.1136/bmj.b1334
4. Department of Health 2009 The government's response to The Health Select Committee report on health inequalities. London: Department of Health. Available: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_099781. Accessed 20 July 2010
5. The Marmot Review 2010 Consultation on the first phase of the Strategic Review of Health Inequalities in England post 2010. Available: http://www.marmotreview.org/. Accessed 27 July 2010
6. WHO Commission on Social Determinants of Health (WHO CSDH) 2008 Closing the gap in a generation: health equity through action on the social determinants of health. Commission on Social Determinants of Health Final Report. Geneva World Health Organization
7. Singh-ManouxA
NabiH
ShipleyM
2008 The role of conventional risk factors in explaining social inequalities in coronary heart disease: the relative and absolute approaches to risk. Epidemiology 9 599 605
8. JhaP
PetoR
ZatonskiW
BorehamJ
JarvisMJ
2006 Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet 368 367 370
9. McLarenL
McIntyreL
KirkpatrickS
2010 Rose's population strategy of prevention need not increase social inequalities in health. Int J Epidemiol 39 372 377
10. RoseG
1992 The strategy of preventive medicine. Oxford Oxford University Press
11. StenderS
DyerbergJ
BystedA
LethT
AstrupA
2006 A trans world journey. Atheroscler Suppl 7 47 52
12. KarppanenH
MervaalaE
2006 Sodium intake and hypertension. Prog Cardiovasc Dis 49 59 75
13. PellJP
HawS
CobbeS
NewbyDE
PellAC
2008 Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 359 482 491
14. LevyDT
ChaloupkFJ
GitchellG
2004 The effects of tobacco control policies on smoking rates: a tobacco control score card. J Public Health Manag Pract 10 338 53
15. EmbersonJ
WhincupP
MorrisR
WalkerM
EbrahimS
2004 Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J 25 484 491
16. WiklundO
WilhelmsenL
ElmfeldtD
WedelH
ValekJ
1980 Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. Atherosclerosis 37 47 53
17. UnalB
CritchleyJ
CapewellS
2005 Modelling the decline in CHD deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention. BMJ 331 614 615
18. CapewellS
FordES
CroftJB
CritchleyJA
GreenlundKJ
2010 Cardiovascular risk factor trends in the US population and options for reducing future CHD mortality. Bull World Health Organ 88 120 130
19. MurrayCJ
LauerJA
HutubessyRC
NiessenL
TomijimaN
2003 Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 361 717 725
20. NilungerL
DiderichsenF
BurströmB
ÖstlinP
2004 Using risk analysis in Health Impact Assessment: the impact of different relative risks for men and women in different socio-economic groups. Health Policy 67 215 224
21. KivimäkiM
ShipleyMJ
FerrieJE
Singh-ManouxA
BattyGD
2008 Estimating the impact of ‘best-practice’ interventions on reducing socioeconomic inequalities in coronary heart disease mortality in a working population: the Whitehall study. Lancet 372 1648 1654
22. EdwardsR
HasselholdtCP
HargreavesK
ProbertC
HolfordR
2006 Levels of second hand smoke in pubs and bars by deprivation and food-serving status: a cross-sectional study from North West England. BMC Public Health 6 42 doi:10.1186/1471-2458-6-42
23. SchaapMM
KunstAE
LeinsaluM
RegidorE
EkholmO
2008 Effect of nation-wide tobacco control policies on smoking cessation in high and low educated groups in 18 European countries. Tob Control 17 248 255
24. TownsendJ
RoderickP
CooperJ
1994 Cigarette smoking by socioeconomic group, sex, and age: effects of price, income, and health publicity. BMJ 309 923 927
25. MainC
ThomasS
OgilvieD
StirkL
PetticrewM
2008 Population tobacco control interventions and their effects on social inequalities in smoking: placing an equity lens on existing systematic reviews. BMC Public Health 8 178
26. GreavesL
HemsingN
2009 Women and tobacco control policies: social-structural and psychosocial contributions to vulnerability to tobacco use and exposure. Drug Alcohol Depend 104 Suppl 1 S121 S130
27. Food Standards Agency 2007 Low income diet and nutrition survey.
NelsonM
ErensB
BatesB
ChurchS
BoshierT
Volumes 1–3 TSO London
28. DowdJB
AielloAE
2008 Did national folic acid fortification reduce socioeconomic and racial disparities in folate status in the US? Int J Epid 37 1059 1066
29. NHS CRD 2000 Systematic review of the efficacy and safety of the fluoridation of drinking water. Report 18. York: NHS Centre for Reviews and Dissemination, University of York
30. BiermanAS
AhmadF
AngusJ
GlazierRH
VahabiM
2009 Burden of illness.
ShillerSK
BiermanAS
The POWER report. Volume 1. Toronto: Project for an Ontario Women's Health Evidence-Based Report. Available: http://www.powerstudy.ca. Accessed 20 July 2010
31. Nuffield Council on Bioethics 2007 Public health: ethical issues. London Nuffield Council on Bioethics
32. GrahamH
2007 Unequal lives: health and socioeconomic inequalities. Buckingham Open University Press
33. McCollK
2009 Betting on health. BMJ 338 b1456 doi:10.1136/bmj.b1456
34. ManuelDG
LimJ
TanuseputroP
AndersonGM
AlterDA
2006 Revisiting Rose: strategies for reducing coronary heart disease. BMJ 332 659 662 doi:10.1136/bmj.332.7542.659
35. WhincupPH
EmbersonJ
MorrisR
2006 Impact of population strategy greatly underestimated. BMJ 332: 659. http://www.bmj.com/cgi/eletters/332/7542/659#130902
36. ZulmanDM
VijanS
OmennGS
HaywardRA
2008 The relative merits of population-based and targeted prevention strategies. Milbank Q 86 557 580
37. CapewellS
O'FlahertyM
FordES
CritchleyJA
2009 Potential reductions in United States coronary heart disease mortality by treating more patients. Am J Cardiol 103 1703 1709
38. EbrahimS
2005 What is the best strategy for reducing deaths from heart disease? PLoS Med 2 e98 doi:10.1371/journal.pmed.0020098
39. SheridanSL
CrespoE
2008 Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Serv Res 8 60
40. CapewellS
JacksonR
2008 Will screening individuals at high risk of cardiovascular events deliver large benefits? BMJ 337 a1395 doi:10.1136/bmj.a1395
41. BlaxterM
2007 Evidence for the effect on inequalities in health of interventions designed to change behaviour. Bristol: Department of Social Medicine, University of Bristol. NICE BC 6-5. Available: http://www.nice.org.uk/nicemedia/pdf/EvidencefortheeffectonInequalitiesdesignedtochangebehavior.pdf. Accessed 20 July 2010
42. WhiteM
AdamsJ
HeywoodP
2009 How and why do interventions that increase health overall widen inequalities within populations?
BabonesS
Health, inequality and society Bristol Policy Press
43. Tudor HartJ
1971 The inverse care law. Lancet 1971 1 405 412
44. TugwellP
de SavignyD
HawkerG
RobinsonV
2006 Applying clinical epidemiological methods to health equity: the equity effectiveness loop. BMJ 332 358 361
45. BanksE
BeralV
CameronR
HoggA
LangleyN
2002 Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res 4 R1
46. FrohlichKL
PotvinL
2008 The inequality paradox: the population approach and vulnerable populations. Am J Public Health 98 216 221
47. PayneRA
MaxwellSR
2009 Deprivation-based risk scores: the re-emergence of postcode prescribing in the UK? J Cardiovasc Med (Hagerstown) 10 157 160
48. BlackmanT
2007 Statins, saving lives, and shibboleths. BMJ 334 902 doi:10.1136/bmj.39163.563519.55
49. ThomsenRW
JohnsenSP
OlesenAV
MortensenJT
BøggildH
2005 Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharm 60 534 542
50. AshworthM
MillettC
2008 Quality improvement in UK primary care: the role of financial incentives. J Ambul Care Manage 31 220 225
51. VrijensB
VinczeG
KristantoP
UrquhartJ
BurnierM
2008 Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 336 1114 1117
52. MoriskyD
AngA
Krousel-WoodM
WardHJ
2008 predictive validity of a medication adherence measure in an outpatient setting. Clin Hypertension 10 348 354
53. JohnellK
RåstamL
LithmanT
SundquistJ
MerloJ
2005 Low adherence with antihypertensives in actual practice: the association with social participation – a multilevel analysis. BMC Public Health 5 17 doi:10.1186/1471-2458-5-17
54. ChaudhryHJ
McDermottB
2008 Recognizing and improving patient non-adherence to statin therapy. Current Ather Rep 10 19 24
55. BouchardMH
DragomirA
BlaisL
BérardA
PilonD
2007 Impact of adherence to statins on coronary artery disease in primary prevention. Br J Clin Pharmacol 63 698 708
56. LowA
UnsworthL
MillerI
2007 Avoiding the danger that stop smoking services may exacerbate health inequalities: building equity into performance assessment. BMC Public Health 7 198
57. BrowningKK
FerketichAK
SalsberryPJ
WewersME
2008 Socioeconomic disparity in provider-delivered assistance to quit smoking. Nicotine Tob Res 10 55 61 doi:10.1080/14622200701704905
58. BauldL
JudgeK
PlattS
2007 Assessing the impact of smoking cessation services on reducing health inequalities in England. Tob Control 16 400 404
59. JakobsenM
2009 Cardiovascular disease prevention: INTER99 [PhD dissertation]. Copenhagen University of Copenhagen
60. KanjilalS
GreggEW
ChengYJ
ZhangP
NelsonDE
2006 Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med 166 2348 2355
61. OldroydJ
BurnsC
LucasP
HaikerwalA
WatersE
2008 The effectiveness of nutrition interventions on dietary outcomes by relative social disadvantage: a systematic review. J Epidemiol Community Health 62 573 579 doi:10.1136/jech.2007.066357
62. HelmertU
SheaS
Maschewsky-SchneiderU
1995 Social class and cardiovascular disease risk factor changes in West Germany 1984–1991. Eur J Public Health 1995 5 103 108 doi:10.1093/eurpub/5.2.103
63. NICE PHIAC 2008 Identifying and supporting people most at risk of dying prematurely. London: National Institute for Health and Clinical Excellence. Available: http://www.nice.org.uk/guidance/PH15. Accessed 20 July 2010
64. BeagleholeR
Epping-JordanJ
PatelV
ChopraM
EbrahimS
2007 Improving the prevention and management of chronic disease in low-income and middle- income countries: a priority for primary health care. Lancet 372 940 949
65. CannonCP
2009 Can the polypill save the world from heart disease? Lancet 373 1313 1314
66. LawsonK
FenwickE
PellJ
2009 Cardiovascular disease strategies for identifying people at high risk of cost effectiveness of alternative screening. J Epid Community Health 63 93
67. WeinehallL
HellstenG
BomanK
HallmansG
AsplundK
2001 Can a sustainable community intervention reduce the health gap? —10-year evaluation of a Swedish community intervention program for the prevention of cardiovascular disease. Scand J Public Health Suppl 56 59 68
68. MacintyreS
200 Prevention and the reduction of health inequalities. BMJ 320 1399 400
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 8
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Using Touchscreen Electronic Medical Record Systems to Support and Monitor National Scale-Up of Antiretroviral Therapy in Malawi
- Physical Activity Attenuates the Genetic Predisposition to Obesity in 20,000 Men and Women from EPIC-Norfolk Prospective Population Study
- Challenges in Developing Evidence-Based Recommendations Using the GRADE Approach: The Case of Mental, Neurological, and Substance Use Disorders
- Reducing Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies